⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ORGO News
Organogenesis Holdings Inc. Class A Common Stock
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
globenewswire.com
ORGO
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
globenewswire.com
ORGO
OTR Therapeutics Enters Strategic Collaboration with LG Chem to Accelerate Development of Novel Oncology Therapies
prnewswire.com
ORGO
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
globenewswire.com
ORGO
Digital Health Tools Are Reshaping Healthcare in the United States
prnewswire.com
AI
CDNA
AZN
ORGO
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
globenewswire.com
IART
VCEL
ORGO
MDXG
CNXU
Form 8-K
sec.gov
ORGO
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
globenewswire.com
CNXU
ORGO
IART
VCEL
MDXG
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
prnewswire.com
IART
ORGO
MDXG
BVS
CNXU
NOWDiagnostics Appoints Lisa Nibauer as Chief Executive Officer to Lead Next Phase of Innovation and Transformation
prnewswire.com
ORGO
BDX